On the contrary, like our findings in CRC, it was also reported that CPT2 played an oncogenic function in triple-negative breast cancer (TNBC) cells [30, 31], suggesting that CPT2 may play distinct functions in different types of cancer. Here, CPT2 is linked to triple-negative breast carcinoma.